Gene · 10733
Papers2,106
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,106
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oncogenic lncRNA transgene transcription modulates epigenetic memory at a naïve chromosomal locus. | Nucleus | 2025 | 40745906 | PubTator, text mining | PubMed |
| Evolution of strain diversity and virulence factor repertoire in pediatric Staphylococcus aureus isolates. | PLoS One | 2025 | 40743055 | PubTator, text mining | PubMed |
| Polyploid giant cancer cells and tumor budding: translation from basic research to clinical application. | Front Oncol | 2025 | 40740858 | PubTator, text mining | PubMed |
| Ribosomal protein L5 induces cellular senescence via p53-p21-pRb pathway to mediate relapse of acute myeloid leukemia. | Sci Rep | 2025 | 40730599 | PubTator, text mining | PubMed |
| Transfer Learning for Heterocycle Retrosynthesis. | J Chem Inf Model | 2025 | 40729356 | PubTator, text mining | PubMed |
| Centriole Duplication at the Crossroads of Cell Cycle Control and Oncogenesis. | Cells | 2025 | 40710347 | PubTator, text mining | PubMed |
| The Unkempt RNA-binding protein reveals a local translation program in centriole overduplication. | J Cell Biol | 2025 | 40699149 | PubTator, text mining | PubMed |
| Investigation of effects of CFI-400945 and ionizing radiation on DNA damage response in triple-negative breast cancer. | Transl Cancer Res | 2025 | 40687253 | PubTator, text mining | PubMed |
Discovery of novel dual-targeting inhibitors against PLK1-PBD and PLK4-PB3: structure-guided pharmacophore modelling, virtual screening, molecular docking, molecular dynamics simulation, and biological evaluation. | J Enzyme Inhib Med Chem | 2025 | 40662493 | PubTator, text mining | PubMed |
| Rational design of CZL-S092: A novel indazole-based PLK4 inhibitor targeting neuroblastoma through virtual screening and fragment-based drug design strategies. | Eur J Med Chem | 2025 | 40541113 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of novel N-(1H-indazol-6-yl)benzenesulfonamide derivatives as potent PLK4 inhibitors. | RSC Med Chem | 2025 | 40521341 | PubTator, text mining | PubMed |
| Role of PLK4 inhibition in cancer therapy. | Cancer Metastasis Rev | 2025 | 40512236 | PubTator, text mining | PubMed |
| The advances in acetylation modification in senescence and aging-related diseases. | Front Physiol | 2025 | 40421455 | PubTator, text mining | PubMed |
| 1-year outcomes of single bolus r-SAK before primary PCI for STEMI: The follow-up of OPTIMA-5. | J Biomed Res | 2025 | 40396270 | PubTator, text mining | PubMed |
| Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor. | J Med Chem | 2025 | 40378279 | PubTator, text mining | PubMed |
| Histone modifications and metabolic reprogramming in tumor-associated macrophages: a potential target of tumor immunotherapy. | Front Immunol | 2025 | 40375990 | PubTator, text mining | PubMed |
| Binding of CEP152 to PLK4 stimulates kinase activity to promote centriole assembly. | Mol Biol Cell | 2025 | 40372713 | PubTator, text mining | PubMed |
| PLK4 Inhibition as a Strategy to Enhance Non-Small Cell Lung Cancer Radiosensitivity. | Mol Cancer Ther | 2025 | 40296663 | PubTator, text mining | PubMed |
| M phase-specific generation of supernumerary centrioles in cancer cells. | Mol Biol Cell | 2025 | 40266756 | PubTator, text mining | PubMed |
| PLK4: Master Regulator of Centriole Duplication and Its Therapeutic Potential. | Cytoskeleton (Hoboken) | 2025 | 40257113 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10733/papers?page=4